To investigate whether depletion of LCA in insulin-treated mice impacts colitis, we treated mice with DSS-induced colitis with GW4064, a farnesoid X receptor (FXR) agonist, via oral gavage to suppress hepatic bile acid synthesis (Fig. 6E). This evidence concerns the gene NR1H4 and colitis.